Hehe fruitsalad, you need to talk to a psychologist for your personal problem and sort out what cause your head hurt. It seems I could not help you. LOL.
===A Comparison – The Dendreon story===
1. Dendreon is a NASDAQ-listed health care company in the US(NASDAQ:DNDN)
2. The company is developing similar technology to Prima with its core product Provenge, a therapy treatment for prostate cancer
3. Dendreon has just released results of its Phase III trial of Provenge, with extremely positive results
4. Dendreon’s share price has risen from a 52 week low of US$2.55 to US$19.24 (@17/4/09) on the back of the results
5. Company now has a market capitalisation of around US$1.74B
6. The treatment has a similar therapeutic approach to Prima’s CVac™and paves the way for CVac™’s technology in the ovarian cancermarket
==== Major opportunity Dendreon Has hilghlighted ===
The success of Dendreon highlight the major opportunity that Prima Biomed represents for investors
bet for dollars->a dream?, page-10
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.5¢ |
Change
0.040(11.0%) |
Mkt cap ! $588.3M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 40.5¢ | 36.8¢ | $1.822M | 4.681M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 19739 | 39.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 45420 | 1 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |